comparemela.com
Latest Breaking News On - Latest clinical trial results session - Page 1 : comparemela.com
First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
/PRNewswire/ Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA).
Germany
Norway
Australia
Iceland
Liechtenstein
United-kingdom
Frankfurt
Brandenburg
Stephanie-fuchs
Wolfgang-miesbach
Greg-healy
Kim-odonohue
vimarsana © 2020. All Rights Reserved.